
Screen for the early signs of cancer in 1 blood draw with Lucence INSIGHT
78% of cancer deaths occurred in cases where cancer had not been screened for
How LucenceINSIGHT can help you
Early Detection
Detects early cancer signals before symptoms onset for more treatment options and a better chance of long-term survival.
Accurate
Identifies mutation and signal localization through technology, with high accuracy.
Convenient
Requires only blood draw and is non-fasting.
Comprehensive
Evaluates the signal of up to 50 types of cancer.
How Lucence INSIGHT works
Multicancer early detection tests (MCED)
How it works
This blood test looks for abnormal DNA fragments in the blood that are associated with cancer. These fragments (also known as circulating tumor DNA or ctDNA) are released from cancer cells into the bloodstream, making it possible to detect many different types of cancer with a single blood test.
There are 4 different options of LucenceINSIGHT test. Here’s what each option covers:
The LucenceINSIGHT 5 test checks for 5 different types of cancer, including:
Thyroid cancer
Lung cancer
Liver cancer
Pancreatic cancer
Colorectal cancer
The LucenceINSIGHT 7 test is for women, and checks for 7 different types of cancer, including:
Thyroid cancer
Lung cancer
Liver cancer
Pancreatic cancer
Colorectal cancer
Breast cancer
Ovarian cancer
The LucenceINSIGHT 12 test checks for 12 different types of cancer, including:
Breast cancer
Lung cancer (both small cell and non small cell lung cancers)
Lung neuroendocrine tumors
Nasopharyngeal cancer
Liver cancer
Biliary tract cancer
Cervical cancer
Gastrointestinal stromal tumor (GIST)
Pancreatic cancer
Colorectal cancer
Prostate cancer
The LucenceINSIGHT 50 checks for 50 different types of cancer. In addition to the cancers listed above, this test also checks for:
Thyroid cancer
Esophageal cancer
Eye cancer
Oropharyngeal cancer
Laryngeal cancer
Salivary gland cancer
Non Hodgkin lymphoma
Hairy cell leukemia
Acute myeloid leukemia
Mast cell tumor
Myeloproliferative neoplasms
Myeloma
Kidney cancer
Adult Wilms tumor
Adrenal gland cancer
Stomach cancer
Stomach neuroendocrine tumors
Small intestine cancer
Colorectal neuroendocrine tumors
Bladder cancer
Endometrial cancer
Ovarian cancer
Ovarian germ cell and stromal tumors
Vulvar cancer
Penile cancer
Testis cancer
Soft tissue cancer
Bone cancer
Skin cancer
Accuracy
Lucence INSIGHT screens for the risk of cancer with a sensitivity of 80.9%. This means that it has an 80.9% chance to correctly detect cases of the particular disease in question. It also has a specificity of 99%, which means that it can correctly identify when a person being tested does not have the disease 99% of the time.
Get tested, for your benefit
Understand your risks, for your benefit — book a consultation with our specialist doctor to better understand your risks.
Specialist consultation with LucenceINSIGHT
LucenceINSIGHT 5 (inclusive of the test and consultation) - $1199
LucenceINSIGHT 7 (inclusive of the test and consultation) - $1499
LucenceINSIGHT 12 (inclusive of the test and consultation) - $1988
LucenceINSIGHT 50 (inclusive of the test and consultation) - $3888
Prices are subject to prevailing GST